BioHarvest Sciences Inc. announced a non-brokered private placement of convertible notes for the gross proceeds of CAD 12,000,000 on October 19, 2023. The notes will have a term of 24 months, and pay interest of 12% per annum. The convertible notes and accrued interest will be convertible at the option of the holder into common shares of the Issuer at a conversion price that is equal to the closing market price of the company?s common shares on the date of conversion less a discount of 20% but in any event, not less than CAD 0.24 per share or more than CAD 0.75 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 CAD | +1.96% | 0.00% | +20.93% |
1st Jan change | Capi. | |
---|---|---|
+20.93% | 109M | |
+8.20% | 7.78B | |
+10.20% | 6.52B | |
-8.10% | 3.67B | |
-13.13% | 3.44B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-42.27% | 879M | |
-18.90% | 836M | |
-16.45% | 802M |
- Stock Market
- Equities
- BHSC Stock
- News BioHarvest Sciences Inc.
- BioHarvest Sciences Inc. announced that it expects to receive CAD 12 million in funding